Synthace Blog

Change Management

3 reasons why DOE rollouts fail (and what to do about it)

DOE rollouts fail all the time. They're high risk, but high reward. How do you give you and your team the greatest chance of success in a DOE rollout?

Lauren Fovargue, PhD

 12 min

Design of Experiments (DOE)

What is Design of Experiments (DOE)?

What is Design of Experiments? In this series of blogs, we'll explore the foundations of DOE, who it's for, and the benefits of using it.

Michael "Sid" Sadowski, PhD

 11 min

Platform Updates

How we plan, run, and record experiments: a transfection example

Our lab team recently ran a series of transfection experiments on Synthace. Read on to see exactly how easy it is to capture a complete digital record.

Nuno Leitão, PhD

 8 min

Design of Experiments (DOE)

High Dimensional Experimentation: a new era for assay development

What comes after Design of Experiments? The short answer is HDE, or High Dimensional Experimentation, and it's going to revolutionize assay development.

Markus Gershater, PhD

 8 min

Platform Updates

How to stay in control of your experimental campaign

We recently introduced the Experiment Map to Synthace, which captures a digital record of your entire experiment - automatically.

Lucia Dunajová, PhD

 7 min

Platform Updates

How to capture intent and context in your experiments

We recently introduced Grouping and Annotations to Synthace so you can capture context, information and data as part of your experimental design.

Nuno Leitão, PhD

 5 min

Platform Updates

Manual pipetting just got a lot easier

We’ve introduced Manual Execution Mode to the Synthace platform to offload admin work and make it easier and quicker to get started on experiments.

Nuno Leitão, PhD

 5 min

Platform Updates

Four more ways Synthace makes your experiments more likely to succeed

We’ve added features to the Synthace platform that address these four experimental challenges directly, and we think you’re going to like them.

Sam Oliver

 5 min

Data

Are ELNs a Dead End?

The short answer is: yes, and it’s a serious problem in life sciences R&D. How do we make our data less fragile and move past our dependency on ELNs?

Markus Gershater, PhD

 5 min